Search Result

Results for "

formic-acid-ammonium-salt

" in MCE Product Catalog:

By Targets:	Amyloid-β (4) CGRP Receptor (2) Formyl Peptide Receptor (FPR) (3) GCGR (3) Insulin Receptor (1) Isotope-Labeled Compounds (1) PD-1/PD-L1 (2) TNF Receptor (1)
By Research Areas:	Cancer (3) Inflammation/Immunology (7) Metabolic Disease (6) Neurological Disease (4)

Inhibitors & Agonists

Peptides

Isotope-Labeled Compounds

Targets Recommended: Salt-inducible Kinase (SIK) Amino Acid Derivatives Hydroxycarboxylic Acid Receptor (HCAR) Free Fatty Acid Receptor Fatty Acid Synthase (FASN) Apical Sodium-Dependent Bile Acid Transporter G protein-coupled Bile Acid Receptor 1

Cat. No.	Product Name	Target	Research Areas

HY-P3783

(Nle35)-Amyloid β-Protein (1-42) (ammonium)
Amyloid-β Others

(Nle35)-Amyloid β-Protein (1-42) ammonium is a peptide.

*(Nle35)-Amyloid β-Protein (1-42) (ammonium)*	Amyloid-β	Others
(Nle35)-Amyloid β-Protein (1-42) ammonium is a peptide.

HY-P3860

*Biotinyl-Amyloid β-Protein (1-42) (ammonium)*	Amyloid-β	Neurological Disease
Biotinyl-Amyloid β-Protein (1-42) ammonium is a biotinylated Amyloid β-Protein (1-42) (HY-P1363). Biotinyl-Amyloid β-Protein (1-42) ammonium can be used for the research of Aβ1-42 converts to Aβ1-40 in brain.

HY-P3908

*FITC-β-Ala-Amyloid β-Protein (1-42) (ammonium)*	Amyloid-β	Neurological Disease
FITC-β-Ala-Amyloid β-Protein (1-42) ammonium is a FITC tagged Aβ1-42 monomer peptide. Aβ1-42 plays a key role in the pathogenesis of Alzheimer’s disease.

HY-P3909

*Biotinyl-Ahx-Amyloid β-Protein (1-42) (ammonium)*	Amyloid-β	Neurological Disease
Biotinyl-Ahx-Amyloid β-Protein (1-42) ammonium is a N-terminally biotin-labeled Amyloid β-Protein (1-42). Amyloid β-protein is the primary component of both vascular and parenchymal amyloid deposits in Alzheimer's disease.

HY-P0224

N-Formyl-Met-Leu-Phe fMLP; N-Formyl-MLF	TNF Receptor	Inflammation/Immunology
N-Formyl-Met-Leu-Phe (fMLP; N-Formyl-MLF) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR). N-Formyl-Met-Leu-Ph is reported to inhibit TNF-alpha secretion.

HY-P1744

N-Formyl-Met-Leu-Phe-Lys fMLFK	Formyl Peptide Receptor (FPR)	Inflammation/Immunology
N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC₅₀s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D281^7.32G, respectively.

HY-P1591A

N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA	Formyl Peptide Receptor (FPR)	Inflammation/Immunology
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist.

HY-P1591

N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys For-Nle-Leu-Phe-Nle-Tyr-Lys-OH	Formyl Peptide Receptor (FPR)	Inflammation/Immunology
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist.

HY-P3255

DA-JC4	Insulin Receptor	Inflammation/Immunology Neurological Disease
DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signaling pathways.

HY-P3143

BMSpep-57	PD-1/PD-L1	Cancer
BMSpep-57 is a potent and competitive macrocyclic peptide inhibitor of PD-1/PD-L1 interaction with an IC₅₀ of 7.68 nM. BMSpep-57 binds to PD-L1 with K_ds of 19 nM and 19.88 nM in MST and SPR assays, respectively. BMSpep-57 facilitates T cell function by in creasing IL-2 production in PBMCs.

HY-P3143A

BMSpep-57 hydrochloride	PD-1/PD-L1	Cancer
BMSpep-57 hydrochloride is a potent and competitive macrocyclic peptide inhibitor of PD-1/PD-L1 interaction with an IC₅₀ of 7.68 nM. BMSpep-57 hydrochloride binds to PD-L1 with K_ds of 19 nM and 19.88 nM in MST and SPR assays, respectively. BMSpep-57 hydrochloride facilitates T cell function by in creasing IL-2 production in PBMCs.

HY-P1731

Tirzepatide LY3298176	GCGR	Metabolic Disease
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes.

HY-P1731B

Tirzepatide hydrochloride LY3298176 hydrochloride	GCGR	Metabolic Disease
Tirzepatide hydrochloride (LY3298176 hydrochloride) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes.

HY-P1731A

Tirzepatide TFA LY3298176 TFA	GCGR	Metabolic Disease
Tirzepatide TFA (LY3298176 TFA) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes.

HY-P3462

Cagrilintide	CGRP Receptor	Metabolic Disease
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity.

HY-P3462A

Cagrilintide acetate	CGRP Receptor	Metabolic Disease
Cagrilintide acetate is a non-selective AMYR/CTR agonist and long-acting acylated amylase analogue. Cagrilintide acetate causes a reduction in food intake and significant weight loss in a dose-dependent manner. Cagrilintide acetate can be used in obesity studies.

HY-P0014S

Liraglutide-d8 triTFA
Isotope-Labeled Compounds Others

Liraglutide-d₈ (triTFA) is the deuterium labeled Liraglutide (HY-P0014)[1].

Liraglutide-d8 triTFA	Isotope-Labeled Compounds	Others
Liraglutide-d₈ (triTFA) is the deuterium labeled Liraglutide (HY-P0014)[1].

Cat. No.	Product Name	Target	Research Area

HY-P3783

(Nle35)-Amyloid β-Protein (1-42) (ammonium)
Amyloid-β Others

(Nle35)-Amyloid β-Protein (1-42) ammonium is a peptide.

*(Nle35)-Amyloid β-Protein (1-42) (ammonium)*	Amyloid-β	Others
(Nle35)-Amyloid β-Protein (1-42) ammonium is a peptide.

HY-P3860

*Biotinyl-Amyloid β-Protein (1-42) (ammonium)*	Amyloid-β	Neurological Disease
Biotinyl-Amyloid β-Protein (1-42) ammonium is a biotinylated Amyloid β-Protein (1-42) (HY-P1363). Biotinyl-Amyloid β-Protein (1-42) ammonium can be used for the research of Aβ1-42 converts to Aβ1-40 in brain.

HY-P3908

*FITC-β-Ala-Amyloid β-Protein (1-42) (ammonium)*	Amyloid-β	Neurological Disease
FITC-β-Ala-Amyloid β-Protein (1-42) ammonium is a FITC tagged Aβ1-42 monomer peptide. Aβ1-42 plays a key role in the pathogenesis of Alzheimer’s disease.

HY-P3909

*Biotinyl-Ahx-Amyloid β-Protein (1-42) (ammonium)*	Amyloid-β	Neurological Disease
Biotinyl-Ahx-Amyloid β-Protein (1-42) ammonium is a N-terminally biotin-labeled Amyloid β-Protein (1-42). Amyloid β-protein is the primary component of both vascular and parenchymal amyloid deposits in Alzheimer's disease.

HY-P1756

N-Formyl-Met-Ala-Ser
Peptides Inflammation/Immunology

N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.

N-Formyl-Met-Ala-Ser	Peptides	Inflammation/Immunology
N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.

HY-P0224

N-Formyl-Met-Leu-Phe fMLP; N-Formyl-MLF	TNF Receptor	Inflammation/Immunology
N-Formyl-Met-Leu-Phe (fMLP; N-Formyl-MLF) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR). N-Formyl-Met-Leu-Ph is reported to inhibit TNF-alpha secretion.

HY-P1744

N-Formyl-Met-Leu-Phe-Lys fMLFK	Formyl Peptide Receptor (FPR)	Inflammation/Immunology
N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC₅₀s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D281^7.32G, respectively.

HY-P3129

KRAS G13D peptide, 25 mer	Peptides	Cancer Inflammation/Immunology
KRAS G13D peptide, 25 mer, a KRAS activating oncogene mutation peptide, is an immune potentiator extracted from patent WO2018144775A1. KRAS G13D peptide, 25 mer can be used to prepare KRAS vaccine.

HY-P1591A

N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA	Formyl Peptide Receptor (FPR)	Inflammation/Immunology
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist.

HY-P1591

N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys For-Nle-Leu-Phe-Nle-Tyr-Lys-OH	Formyl Peptide Receptor (FPR)	Inflammation/Immunology
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist.

HY-P3255

DA-JC4	Insulin Receptor	Inflammation/Immunology Neurological Disease
DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signaling pathways.

HY-P3143

BMSpep-57	PD-1/PD-L1	Cancer
BMSpep-57 is a potent and competitive macrocyclic peptide inhibitor of PD-1/PD-L1 interaction with an IC₅₀ of 7.68 nM. BMSpep-57 binds to PD-L1 with K_ds of 19 nM and 19.88 nM in MST and SPR assays, respectively. BMSpep-57 facilitates T cell function by in creasing IL-2 production in PBMCs.

HY-P3143A

BMSpep-57 hydrochloride	PD-1/PD-L1	Cancer
BMSpep-57 hydrochloride is a potent and competitive macrocyclic peptide inhibitor of PD-1/PD-L1 interaction with an IC₅₀ of 7.68 nM. BMSpep-57 hydrochloride binds to PD-L1 with K_ds of 19 nM and 19.88 nM in MST and SPR assays, respectively. BMSpep-57 hydrochloride facilitates T cell function by in creasing IL-2 production in PBMCs.

HY-P1731

Tirzepatide LY3298176	GCGR	Metabolic Disease
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes.

HY-P1731B

Tirzepatide hydrochloride LY3298176 hydrochloride	GCGR	Metabolic Disease
Tirzepatide hydrochloride (LY3298176 hydrochloride) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes.

HY-P1731A

Tirzepatide TFA LY3298176 TFA	GCGR	Metabolic Disease
Tirzepatide TFA (LY3298176 TFA) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes.

HY-P3462

Cagrilintide	CGRP Receptor	Metabolic Disease
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity.

HY-P3462A

Cagrilintide acetate	CGRP Receptor	Metabolic Disease
Cagrilintide acetate is a non-selective AMYR/CTR agonist and long-acting acylated amylase analogue. Cagrilintide acetate causes a reduction in food intake and significant weight loss in a dose-dependent manner. Cagrilintide acetate can be used in obesity studies.

HY-P4070

Insulin icodec
Peptides Metabolic Disease

Insulin icodec is a basal insulin analog. Insulin icodec can be used for the research of type 2 diabetes.

Insulin icodec	Peptides	Metabolic Disease
Insulin icodec is a basal insulin analog. Insulin icodec can be used for the research of type 2 diabetes.

Cat. No.	Product Name

HY-P0014S

Liraglutide-d8 triTFA

Liraglutide-d₈ (triTFA) is the deuterium labeled Liraglutide (HY-P0014)[1].